Trade BIO-key International, Inc. - BKYI CFD

BIO-key International, Inc. Company profile

About BIO-key International, Inc.

BIO-key International, Inc. is an identity and access management (IAM) platform provider enabling secure work-from-anywhere for enterprise, education, and government customers. The Company's products include PortalGuard and PortalGuard identity-as-a-service (IDaaS) enterprise IAM, WEB-key biometric civil and large-scale ID infrastructure, and accessory hardware to customers. PortalGuard IDaaS offers flexible single sign-on and authentication options to meet users' security goals and deliver an optimized user experience. WEB-key is a scalable biometric service management platform, incorporating key functions for regulatory compliance, enrollment, authentication or identification, and integrity in a multi-tenant private or public cloud delivery platform. It also offers biometric software integration application programming interfaces (APIs), allowing software developers to leverage its platform to securely embed biometric multi-factor authentication (MFA), into their own products.

Financial summary

BRIEF: For the nine months ended 30 September 2021, BIO-key International, Inc. revenues increased from $1.8M to $4.2M. Net loss applicable to common stockholders decreased 64% to $3M. Revenues reflect License fees increase from $605K to $2M, Hardware increase from $239K to $1.2M, Services increase of 6% to $985K. Lower net loss reflects Interest expense decrease of 100% to $18K (expense), Loss on extinguishment of debt decrease from $499K (expense) to

Equity composition

Common Stock $.0001 Par, 03/11, 170M auth., 78,155,413 issd. Insiders control 0.49%. IPO: 2/97,2,420,000 shares @ $3 by Tuschner & Company, Inc. 7/97, 2-for-1 stock split. Series A Convertible Preferred Stock $.0001 Par, 100K auth., 30,557 issd. Series D Convertible Preferred Stock $.0001 Par, 02/15, 1-for-2 reverse stock split.